Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lung Imaging Technologies (LIT) is a medical technology company specializing in advanced functional imaging solutions for respiratory diseases. The company provides sophisticated software and imaging protocols that allow clinicians to visualize and quantify regional lung function, moving beyond traditional global metrics like spirometry. Their technology is primarily used in clinical research and drug development to assess the efficacy of respiratory therapies and in clinical practice for personalized treatment planning. By providing detailed maps of ventilation and perfusion, LIT helps in the management of conditions such as COPD, asthma, and lung cancer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lung Imaging.